Skip to main content
Clinical Trials/NCT06123117
NCT06123117
Recruiting
Not Applicable

Single Transversus Abdominis Laparoscopy-guided Plane Block Combined With Local Trocar Site Ropivacaine Infiltration (STALL) vs Sole Local Wound Infiltration in LCC (Laparoscopic CholeCystectomy) - Double-blinded Randomized Controlled Trial.

Helsinki University Central Hospital1 site in 1 country850 target enrollmentJanuary 16, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cholelithiasis
Sponsor
Helsinki University Central Hospital
Enrollment
850
Locations
1
Primary Endpoint
cumulative opioid consumption during the stay at the recovery
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

This trial is a prospective randomized superiority trial comparing sole ropivacaine based local trocar site infiltration to local infiltration combined with laparoscopic ropivacaine TAP block (STALL) in LCC.

There are only a few randomized trials comparing sole local anesthesia to additional laparoscopic TAP block in laparoscopic cholecystectomy and they have yet failed to show evidence in favor of TAP block.

We hypothesize STALL (Single Transversus Abdominis Laparoscopy-guided plane block combined with Local trocar site ropivacaine infiltration) is superior to local port site infiltration, provided that the sample size is sufficiently big.

The aim of this randomized study is to compare the efficacy of sole local anesthesia of trocar sites to STALL in LCC.

Registry
clinicaltrials.gov
Start Date
January 16, 2024
End Date
October 1, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roman Kornosev

MD

Helsinki University Central Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients scheduled for elective or emergency LCC, aged over 18 and able to give an informed consent.

Exclusion Criteria

  • Age under 18 years, chronic daily opioid and/or pain tolerance / pain threshold -modifying medication use (abuse), pregnancy, known allergy to local anesthetics, diagnosed severe coagulopathy and incapability to give informed consent for whatever reason.

Outcomes

Primary Outcomes

cumulative opioid consumption during the stay at the recovery

Time Frame: duration of stay at the recovery (estimated 1-4 hours)

all groups; mg, morphine equivalent

Secondary Outcomes

  • cumulative opioid consumption (emergency and inpatient surgery)(while admitted; est. 2 days)
  • maximum NRS score during the day of surgery, after discharge (daycare / outpatient)(30 min after surgery, every 60 min afterwards; 2 days)

Study Sites (1)

Loading locations...

Similar Trials